chartexchange

CRVO
CervoMed Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 2:31:02 PM EST
1.36USD-6.207%(-0.09)200,545
Pre-marketNov 19, 2026 9:24:30 AM EST
1.4716USD+1.490%(+0.0216)
1.3500Bid1.3700Ask0.0200Spread
Loading…
Loading…
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Charlottesville, Virginia, USA
Previous Close
$1.45
Beta
2.13
52-Week High
$10.00 2025-11-28
52-Week Low
$1.27 2026-11-06
SMA 50
$2.28
SMA 200
$3.22
Avg. Vol 10D
1.64M
Avg. Vol 30D
771,175
Avg. Vol 90D
466,584
Relative Vol
0.26
9.61M
32.4900%
2,891
CRVO Profile

diffusion pharmaceuticals is a clinical stage company focused on improving the effectiveness of standard-of-care therapies for life-threatening treatment-resistant solid cancerous tumors, without adding harmful side effects. the company is developing its lead drug, trans sodium crocetinate (tsc), which has received orphan drug designation from the fda for use in a number of cancers in which tumor hypoxia (oxygen deprivation) diminishes the efficacy of current treatments. tsc targets the cancer's hypoxic micro-environment, re-oxygenating treatment-resistant tissue and making the cancerous cells more vulnerable to the therapeutic effects of conventional radiation and chemotherapy. the company is poised to begin a pivotal phase 3 trial in glioblastoma (gbm) in 2016. other programs include planned phase 2/3 trials in pancreatic cancer and brain metastases. because tsc's novel mechanism safely re-oxygenates a wide range of tumor types, its use is not limited to a specific tumor tissue, but

CRVO Performance
PeriodPriceDateChangeBeta
1W1.832026-11-12-25.41%-2.203
1M2.312026-10-19-40.91%2.528
3M2.712026-08-19-49.63%2.239
6M2.892026-05-19-52.77%2.236
1Y8.622025-11-19-84.16%2.125
2Y10.082024-11-19-86.46%—
5Y5.882023-08-18-76.79%1.305
CRVO Stock Summary

CervoMed Inc. Common Stock (NASDAQ:CRVO) stock price today is $1.37, and today's volume is 199,143. CRVO is down 5.862% today. The 30 day average volume is 771,175. CRVO market cap is $20.65M with 15.13M shares outstanding.